chrX-154364584-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_001110556.2(FLNA):c.1964G>A(p.Arg655His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000048 in 1,208,958 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001110556.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNA | NM_001110556.2 | c.1964G>A | p.Arg655His | missense_variant | 13/48 | ENST00000369850.10 | NP_001104026.1 | |
FLNA | NM_001456.4 | c.1964G>A | p.Arg655His | missense_variant | 13/47 | NP_001447.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNA | ENST00000369850.10 | c.1964G>A | p.Arg655His | missense_variant | 13/48 | 1 | NM_001110556.2 | ENSP00000358866.3 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111580Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33754
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 180931Hom.: 0 AF XY: 0.0000298 AC XY: 2AN XY: 67199
GnomAD4 exome AF: 0.0000492 AC: 54AN: 1097378Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 17AN XY: 363212
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111580Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33754
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 12, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2023 | See Variant Classification Assertion Criteria. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 17, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Dec 07, 2020 | This FLNA variant (rs782563602) is rare (<0.1%) in a large population dataset (gnomAD: 8/202666 total alleles; 0.004%; no homozygotes) and has not been reported in the literature, to our knowledge. This variant has been reported in ClinVar. Of three bioinformatics tools queried, two predicts that the substitution would be damaging, while one predicts that it would be tolerated. The arginine residue at this position is evolutionarily conserved across most mammals assessed. We consider the clinical significance of c.1964G>A to be uncertain at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | FLNA: PP2, BS2 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 14, 2020 | DNA sequence analysis of the FLNA gene demonstrated a sequence change, c.1964G>A, in exon 13 that results in an amino acid change, p.Arg655His. This sequence change does not appear to have been previously described in patients with FLNA-related disorders and has been described in the gnomAD database with a frequency of 0.025% in Latino populations (dbSNP rs782563602). The p.Arg655His change affects a moderately conserved amino acid residue located in a domain of the FLNA protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg655His substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Arg655His change remains unknown at this time. - |
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at